← Back to Clinical Trials
Recruiting NCT01885299

NCT01885299 RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01885299
Status Recruiting
Phase
Sponsor The Radiosurgery Society
Condition Neoplasms
Study Type OBSERVATIONAL
Enrollment 50,000 participants
Start Date 2012-03
Primary Completion 2030-12

Trial Parameters

Condition Neoplasms
Sponsor The Radiosurgery Society
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2012-03
Completion 2030-12
Interventions
SRS/SBRT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Eligibility Criteria

Inclusion Criteria: * Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy * Willingness to sign an Informed Consent Document or verbally agree to participation Exclusion Criteria: * There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology